·Î±×ÀÎ ¸¶ÀÌÆäÀÌÁö ÀÌ¿ë¾È³» °í°´¼¾ÅÍ ¼­ºñ½º¾È³»
ä¿ëÁ¤º¸µî·Ï À̷¼­µî·Ï
ä¿ëÁ¤º¸ ÇìµåÇåÆà ÀÎÀçÁ¤º¸ Ä¿¹Â´ÏƼ °í°´¼¾ÅÍ ¼îÇθô
±â¾÷ȸ¿ø¼­ºñ½º°³ÀÎȸ¿ø¼­ºñ½º
Àαâ°Ë»ö¾î : ¿µ¾÷ ¸¶ÄÉÆà ÀÓ»ó ¿¬±¸ Ç°Áú°ü¸® ÀλçÃѹ« »ý»êÁ÷ ¾à»ç ÀÎÇã°¡ °£È£»ç
"regulatory"¿¡ ´ëÇÑ °Ë»ö °á°ú
¾Æº§¸®³ë - ¾Æº§¸®³ë Çѱ¹¹ýÀÎ - GA ( Ãѹ«) ´ã´çÀÚ¸¦ ä¿ëÇÕ´Ï´Ù.
¼­¿ï °­³²±¸ | Çз¹«°ü | °æ·Â¹«°ü | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
ÁÖ½Äȸ»çÇ÷º½ÃÄɾîÄÚ¸®¾Æ - Product specialist (ÀÎÇã°¡, º¸Çè, ¸¶ÄÉÆà ¾÷¹«)
¼­¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ | 1³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
PSI CRO Korea - [PSI CRO Korea] Regulatory Officer / Senior Regulatory Officer
¼­¿ï ¼ÛÆı¸ | Çз¹«°ü | 5³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
Çѱ¹º¤Å©¸¸ÄðÅÍ - [Çѱ¹º¤Å©¸¸ÄðÅÍ] RA SR. SPECIALIST °æ·ÂÁ÷ ä¿ë
¼­¿ï °­³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ | 5³â¡è | ¸¶°¨ÀÏ:»ó½Ãä¿ë
(ÁÖ)ÇÁ·¹Á¦´Ï¿ì½º¸ÞµðÄ®ÄɾîÄÚ¸®¾Æ - QA Associate (1 year contract) Ç°Áú/VOC °ü¸® µî
¼­¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(4³â) Á¹¾÷ | 1³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
Çѱ¹MSD À¯ÇÑȸ»ç - PV Specialist ¸ðÁý(½ÅÀÔÁö¿ø°¡´É/1³â°è¾à±Ù¹«)
¼­¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ | °æ·Â¹«°ü | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
¼¼¿ø¼¿·ÐÅØ(ÁÖ) - ¼¼¿ø¼¿·ÐÅØ(ÁÖ) ÀÇ·á¿ëÇ° ±¹³»¿Ü ÀÎÇã°¡ °æ·Â»ç¿ø ¸ðÁý
¼­¿ï ¼ºµ¿±¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) - [PPC Korea] In-house CRA ä¿ë°ø°í
¼­¿ï °­³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ | °æ·Â¹«°ü | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ)¶õµ¶½ºÄÚ¸®¾Æ - ¶õµ¶½ºÄÚ¸®¾Æ RA QA °æ·Â Á¤±ÔÁ÷ ü¿ÜÁø´Ü¿ë½Ã¾à ¿µ±¹Áö»ç
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ | 1³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
½Ã¹ÍÄÚ¸®¾Æ - [½Ã¹ÍÄÚ¸®¾Æ] Associate Clinical Operations Manager
¼­¿ï °­³²±¸ | Çз¹«°ü | 7³â¡è | ¸¶°¨ÀÏ:»ó½Ãä¿ë
½Ã¹ÍÄÚ¸®¾Æ - [½Ã¹ÍÄÚ¸®¾Æ] Medical Writing Leader ä¿ë
¼­¿ï °­³²±¸ | Çз¹«°ü | °æ·Â¹«°ü | ¸¶°¨ÀÏ:»ó½Ãä¿ë
½Ã¹ÍÄÚ¸®¾Æ - [½Ã¹ÍÄÚ¸®¾Æ] Senior Medical Writer ä¿ë
¼­¿ï °­³²±¸ | Çз¹«°ü | °æ·Â¹«°ü | ¸¶°¨ÀÏ:»ó½Ãä¿ë
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Medical Science Liaison (Cardio-Vascular)
¼­¿ï ¼­Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Regulatory Affairs Specialist
¼­¿ï ¼­Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ - [Sanofi/»ç³ëÇÇ] Medical Science Liaison (Cardio-Vascular)
¼­¿ï ¼­Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ | 3³â¡è | ¸¶°¨ÀÏ:ä¿ë½Ã±îÁö
1   2   3   4   5   6   7   8   9   10  
 
½Ç½Ã°£ Àα⠰˻ö¾î
   CR
   ¸¶ÄÉÆÃ
6
   am
1
   GE
1
   »ý»êÁ÷
4
   cra
12
   ¾à»ç
6
   °£È£»ç
6
   ÀÎÇã°¡
7
   ¿µ¾÷
5
 
°³ÀÎÁ¤º¸Ã³¸®¹æħ | ȸ¿ø¾à°ü | °í°´Áö¿ø¼¾ÅÍ | Á¦ÈÞ ¹× ±¤°í¹®ÀÇ | ´ÙÀÌ·ºÆ®°áÁ¦